RE: Fred nice post mate29 Jun 2019 00:28
ValJu,
Thank you for your update. It was a bit understandable that they had to get EHGO out so fast (they issued the new shares within 30 minutes of getting the resolutions passed) and they now have much less financial headroom to play with.
Did they give any clues away about how they will get further funds in? If EHGO sell the shares that they are being issued it will create a temporary 'overhang' which is likely to depress the share price in the near term, which will mean they will be unable to raise significant sums to proceed with their trials unless more headroom is requested or funds come from other deals.
Was there any mention of the Mystic deal - when I last looked Bangladeshi drug companies had the authority to sell compounds into Indonesia and other Asian countries which represent a huge market, even for a low priced drug.
If EHGO sell as I expect them to, it may create an oversold opportunity for those brave enough / well informed to take advantage of. With a share held mainly by private investors this may be the mother of all x-mas trades in the making (or, as others would have some believe, consolidation and more confetti).